Searched for
ASTHMA TREATMENT DRUG
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...23 May, 2026, 10.24 PM IST- Zydus Lifesciences gets USFDA nod for asthma treatment drugZydus Lifesciences Ltd receives final USFDA approval to market generic Theophylline extended-release tablets of strengths 300 mg and 450 mg...22 May, 2024, 03.57 PM IST
- GSK boosts respiratory portfolio with $1.4 bn Aiolos Bio dealGSK will pay $1 billion upfront and up to $400 million in certain success-based regulatory milestone payments. It will also make milestone ...09 Jan, 2024, 05.43 PM IST
- Lupin unit introduces inhaler for asthma patients in GermanyDrug firm Lupin on Friday said its unit has launched a pressurized metered dose inhaler for the treatment of asthma and chronic obstructive...21 Jul, 2023, 03.13 PM IST
- AstraZeneca to open 5 asthma clinics in IndiaThe centers will serve as a hub for the treatment and management of severe asthma patients, and support evolving severe asthma centres for ...02 May, 2023, 09.08 PM IST
- Pollution isn't the only reason. Exercise, money problems & job stress can also trigger asthmaExposure to strong smells such as perfumes and odours can also trigger asthma in patients.03 May, 2022, 05.14 PM IST
- Lupin launches digital asthma educator platformThe new platform is the latest initiative under Lupin's long running umbrella programme, Joint Airways Initiative (JAI), for patients suffe...07 Jun, 2021, 12.04 PM IST
- AstraZeneca gets DCGI nod for asthma drugThe company has received approval from the DCGI for Fasenra (Benralizumab solution for injection in a single dose prefilled syringe30 mg/ml...22 Dec, 2020, 05.37 PM IST
- AstraZeneca Pharma gets DCGI nod to market asthma drugAstraZeneca Pharma said the receipt of this permission paves way for the launch of Benralizumab (Fasenra) in India, subject to the receipt ...21 Dec, 2020, 11.47 AM IST
- Cipla submits application with USFDA for generic version of asthma drugDrug major Cipla on Monday said it has submitted an application with the US health regulator for a generic version of GSK's Advair Diskus, ...18 May, 2020, 10.51 AM IST
- Unichem Labs gets USFDA nod for asthma drugThe tablets are indicated for prophylaxis and chronic treatment of asthma in adults and pediatric patients - 12 months of age and older.04 Jul, 2018, 03.22 PM IST
- USFDA gives final approval to Cipla's anti-asthma productCiting IMS Health data, Cipla said Pulmicort Respules and generic equivalents had US sales of approximately USD 825 million for the 12 mont...17 Nov, 2017, 11.51 AM IST
- AstraZeneca gets marketing nod for asthma drug SymbicortResults from AstraZeneca's two clinical studies have shown that the addition of formoterol to budesonide improved asthma symptoms and lung ...20 Jun, 2017, 07.10 PM IST
- Unichem gets USFDA nod for generic asthma treatment tabletsDrug firm Unichem Laboratories has received approval from the US health regulator for its Montelukast Sodium tablets used in prevention and...09 Oct, 2015, 06.51 PM IST
- AIIMS doctors write to ICMR for cheaper treatment of diseasesThe success of alternative therapies, has led to speculation that the inexpensive, out of patent drugs may be superior to newer expensive a...21 Jul, 2015, 12.20 PM IST
- New treatment for asthma may be just five years awayResearchers described the previously unproven role of the calcium sensing receptor (CaSR) in causing asthma, a disease which affects 300 mi...23 Apr, 2015, 06.28 PM IST
- FDA approves Merck's new lung drug DuleraMerck & Co Inc's new two-in-one respiratory drug Dulera has been approved by the US Food and Drug Administration, the US company said on Th...24 Jun, 2010, 06.47 PM IST
Load More
